我们的见解
Exosomes contribute to anti-aging, including cellular communication, tissue repair, inflammation reduction, and oxidative stress mitigation.
Regenerative medicine including Stem cell and Exosome related products are developed by Biotech Co.. in Taiwan in recent years; But, due to regulation limited, only cosmetic products were approved for...
Exosomes contribute to anti-aging, including cellular communication, tissue repair, inflammation reduction, and oxidative stress mitigation.
Regenerative medicine including Stem cell and Exosome related products are developed by Biotech Co.. in Taiwan in recent years; But, due to regulation limited, only cosmetic products were approved for...
台湾生物科技：商业化与授权——进入全球市场的战略选择
台湾生技公司是否需要将产品商业化？还是只需在第二或第三阶段进行授权交易。台湾生技公司如何在全球市场将新产品商业化？按地区授权？分销商合作，设立分支机构或拥有自己的销售和营销团队，与合作伙伴共同营销。
台湾生物科技：商业化与授权——进入全球市场的战略选择
台湾生技公司是否需要将产品商业化？还是只需在第二或第三阶段进行授权交易。台湾生技公司如何在全球市场将新产品商业化？按地区授权？分销商合作，设立分支机构或拥有自己的销售和营销团队，与合作伙伴共同营销。
美国在全球医药市场的主导地位：对台湾生物科技的启示和战略经验
预计到 2024 年，医药市场的收入将达到 1,1550 亿美元。与全球相比，值得注意的是，预计到 2024 年，美国的收入最高，为 6,303 亿美元。
美国在全球医药市场的主导地位：对台湾生物科技的启示和战略经验
预计到 2024 年，医药市场的收入将达到 1,1550 亿美元。与全球相比，值得注意的是，预计到 2024 年，美国的收入最高，为 6,303 亿美元。
BIOSECURE Act: A Challenge for China, An Opportunity for Taiwan Biotech
On September 9, 2024, the House of Representatives passed HR 8333,1 commonly known as the BIOSECURE Act.2 The bill passed 306-81, far exceeding the two thirds vote required to pass.
BIOSECURE Act: A Challenge for China, An Opportunity for Taiwan Biotech
On September 9, 2024, the House of Representatives passed HR 8333,1 commonly known as the BIOSECURE Act.2 The bill passed 306-81, far exceeding the two thirds vote required to pass.
人工智能在医疗保健领域的变革性作用及其在制药商业化领域的尚未开发的潜力
众所周知，人工智能对当前和未来的人类生活有着重大影响。医疗保健又如何呢？当然，大多数大型制药公司已经将人工智能植入研发和大数据的价值链中，其中包括以下几点……
人工智能在医疗保健领域的变革性作用及其在制药商业化领域的尚未开发的潜力
众所周知，人工智能对当前和未来的人类生活有着重大影响。医疗保健又如何呢？当然，大多数大型制药公司已经将人工智能植入研发和大数据的价值链中，其中包括以下几点……
Taiwan Biotech’s Global Ambition: Building a Team for International Success
The challenge for Taiwan biotech companies entering Global market is international talent , who must have Taiwan base-HQ thinking, global vision, international trade knowledge, expertise of pharmaceutical business development, marketing,...
Taiwan Biotech’s Global Ambition: Building a Team for International Success
The challenge for Taiwan biotech companies entering Global market is international talent , who must have Taiwan base-HQ thinking, global vision, international trade knowledge, expertise of pharmaceutical business development, marketing,...
